Survival outcomes have historically been regarded as worse in NF1-related MPNST (5 year survival rates 16–26%) compared to sporadic cases (42–55%), although a focus on more recent series suggests this difference may be less than previously suspected [4]. Here, NF1 is linked to malignant peripheral nerve sheath tumor.